Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

Cancer Cell

Volumn 7, Issue 3, 2005, Pages 239-249

  Drake, Charles G ^a   Doody, Amy D H ^b   Mihalyo, Marianne A ^b   Huang, Ching Tai ^a,c   Kelleher, Erin ^a   Ravi, Sowmya ^a   Hipkiss, Edward L ^a   Flies, Dallas B ^a   Kennedy, Eugene P ^a   Long, Meixiao ^b   McGary, Patrick W ^b   Coryell, Lee ^b   Nelson, William G ^a   Pardoll, Drew M ^a   Adler, Adam J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE CANCER RESTRICTED ANTIGEN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS BREEDING; DISEASE COURSE; EFFECTOR CELL; EMBRYO; IMMUNOLOGICAL TOLERANCE; MALE; METASTASIS; MOLECULAR RECOGNITION; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VACCINATION;

ANIMALIA; MUS MUSCULUS;

EID: 20244380618     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.01.027     Document Type: Article

References (62)

1. A.J. Adler, A. Scheller, Y. Hoffman, and D.M. Robins Multiple components of a complex androgen-dependent enhancer Mol. Endocrinol. 5 1991 1587 1596
2. A.J. Adler, A. Scheller, and D.M. Robins The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences Mol. Cell. Biol. 13 1993 6326 6335
3. A.J. Adler, D.W. Marsh, G.S. Yochum, J.L. Guzzo, A. Nigam, W.G. Nelson, and D.M. Pardoll CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells J. Exp. Med. 187 1998 1555 1564
4. A.J. Adler, C.T. Huang, G.S. Yochum, D.W. Marsh, and D.M. Pardoll In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions J. Immunol. 164 2000 649 655
5. M.S. Anderson, E.S. Venanzi, L. Klein, Z. Chen, S.P. Berzins, S.J. Turley, H. von Boehmer, R. Bronson, A. Dierich, C. Benoist, and D. Mathis Projection of an immunological self shadow within the thymus by the aire protein Science 298 2002 1395 1401
6. E.R. Barrack TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity Prostate 31 1997 61 70
7. B. Bogen Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma Eur. J. Immunol. 26 1996 2671 2679
8. C.D. Chen, D.S. Welsbie, C. Tran, S.H. Baek, R. Chen, R. Vessella, M.G. Rosenfeld, and C.L. Sawyers Molecular determinants of resistance to antiandrogen therapy Nat. Med. 10 2004 33 39
9. S.R. Denmeade, and J.T. Isaacs A history of prostate cancer treatment Nat. Rev. Cancer 2 2002 389 396
10. J. Derbinski, A. Schulte, B. Kyewski, and L. Klein Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self Nat. Immunol. 2 2001 1032 1039
11. P.L. Earl, and B. Moss Generation of recombinant vaccinia viruses Curr. Prot. Mol. Biol. 2 1993 17 21
12. J. Edwards, N.S. Krishna, K.M. Grigor, and J.M. Bartlett Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer Br. J. Cancer 89 2003 552 556
13. M.H. Eng, L.G. Charles, B.D. Ross, C.E. Chrisp, K.J. Pienta, N.M. Greenberg, C.X. Hsu, and M.G. Sanda Early castration reduces prostatic carcinogenesis in transgenic mice Urology 54 1999 1112 1119
14. T.A. Ferguson, J. Herndon, B. Elzey, T.S. Griffith, S. Schoenberger, and D.R. Green Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness J. Immunol. 168 2002 5589 5595
15. Y. Furuya, X.S. Lin, J.C. Walsh, W.G. Nelson, and J.T. Isaacs Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction Endocrinology 136 1995 1898 1906
16. N.M. Greenberg, F.J. DeMayo, P.C. Sheppard, R. Barrios, R. Lebovitz, M. Finegold, R. Angelopoulou, J.G. Dodd, M.L. Duckworth, and J.M. Rosen The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice Mol. Endocrinol. 8 1994 230 239
17. N.M. Greenberg, F. DeMayo, M.J. Finegold, D. Medina, W.D. Tilley, J.O. Aspinall, G.R. Cunha, A.A. Donjacour, R.J. Matusik, and J.M. Rosen Prostate cancer in a transgenic mouse Proc. Natl. Acad. Sci. USA 92 1995 3439 3443
18. M.B. Gretzer, and A.W. Partin PSA markers in prostate cancer detection Urol. Clin. North Am. 30 2003 677 686
19. J.M. Hakimi, R.H. Rondinelli, M.P. Schoenberg, and E.R. Barrack Androgen-receptor gene structure and function in prostate cancer World J. Urol. 14 1996 329 337
20. H.L. Hanson, D.L. Donermeyer, H. Ikeda, J.M. White, V. Shankaran, L.J. Old, H. Shiku, R.D. Schreiber, and P.M. Allen Eradication of established tumors by CD8+ T cell adoptive immunotherapy Immunity 13 2000 265 276
21. A.D. Higgins, M.A. Mihalyo, and A.J. Adler Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen J. Immunol. 169 2002 3622 3629
22. A.D. Higgins, M.A. Mihalyo, P.W. McGary, and A.J. Adler CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement J. Immunol. 168 2002 5573 5581
23. J. Hu, W. Kindsvogel, S. Busby, M.C. Bailey, Y.Y. Shi, and P.D. Greenberg An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues J. Exp. Med. 177 1993 1681 1690
24. S. Hugues, E. Mougneau, W. Ferlin, D. Jeske, P. Hofman, D. Homann, L. Beaudoin, C. Schrike, M. Von Herrath, A. Lehuen, and N. Glaichenhaus Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells Immunity 16 2002 169 181
25. A.A. Hurwitz, B.A. Foster, E.D. Kwon, T. Truong, E.M. Choi, N.M. Greenberg, M.B. Burg, and J.P. Allison Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade Cancer Res. 60 2000 2444 2448
26. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics, 2003 CA Cancer J. Clin. 53 2003 5 26
27. C. Jolicoeur, D. Hanahan, and K.M. Smith T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus Proc. Natl. Acad. Sci. USA 91 1994 6707 6711
28. L.A. Jones, L.T. Chin, D.L. Longo, and A.M. Kruisbeek Peripheral clonal elimination of functional T cells Science 250 1990 1726 1729
29. M.S. Jordan, A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, M.A. Lerman, A. Naji, and A.J. Caton Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide Nat. Immunol. 2 2001 301 306
30. J. Kirberg, A. Baron, S. Jakob, A. Rolink, K. Karjalainen, and H. von Boehmer Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor J. Exp. Med. 180 1994 25 34
31. C. Kurts, J.F. Miller, R.M. Subramaniam, F.R. Carbone, and W.R. Heath Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction J. Exp. Med. 188 1998 409 414
32. N. Kyprianou, and J.T. Isaacs Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death Mol. Endocrinol. 3 1989 1515 1522
33. K. Liu, T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R.M. Steinman Immune tolerance after delivery of dying cells to dendritic cells in situ. 1 J. Exp. Med. 196 2002 1091 1097
34. M. Long, A.D. Higgins, M.A. Mihalyo, and A.J. Adler Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentials Cell. Immunol. 224 2003 114 121
35. M. Mercader, B.K. Bodner, M.T. Moser, P.S. Kwon, E.S. Park, R.G. Manecke, T.M. Ellis, E.M. Wojcik, D. Yang, and R.C. Flanigan T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer Proc. Natl. Acad. Sci. USA 98 2001 14565 14570
36. M.A. Mihalyo, A.D. Doody, J.P. McAleer, E.C. Nowak, M. Long, Y. Yang, and A.J. Adler In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy J. Immunol. 172 2004 5338 5345
37. D.J. Morgan, R. Liblau, B. Scott, S. Fleck, H.O. McDevitt, N. Sarvetnick, D. Lo, and L.A. Sherman CD8(+) T cell-mediated spontaneous diabetes in neonatal mice J. Immunol. 157 1996 978 983
38. D.J. Morgan, H.T. Kreuwel, S. Fleck, H.I. Levitsky, D.M. Pardoll, and L.A. Sherman Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity J. Immunol. 160 1998 643 651
39. D.J. Morgan, H.T. Kreuwel, and L.A. Sherman Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens J. Immunol. 163 1999 723 727
40. D.L. Mueller, M.K. Jenkins, and R.H. Schwartz Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy Annu. Rev. Immunol. 7 1989 445 480
41. L.T. Nguyen, A.R. Elford, K. Murakami, K.M. Garza, S.P. Schoenberger, B. Odermatt, D.E. Speiser, and P.S. Ohashi Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance J. Exp. Med. 195 2002 423 435
42. A.F. Ochsenbein, S. Sierro, B. Odermatt, M. Pericin, U. Karrer, J. Hermans, S. Hemmi, H. Hengartner, and R.M. Zinkernagel Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction Nature 411 2001 1058 1064
43. P.S. Ohashi, S. Oehen, K. Buerki, H. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R.M. Zinkernagel, and H. Hengartner Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice Cell 65 1991 305 317
44. M.B. Oldstone, M. Nerenberg, P. Southern, J. Price, and H. Lewicki Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response Cell 65 1991 319 331
45. K.A. Pape, R. Merica, A. Mondino, A. Khoruts, and M.K. Jenkins Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance J. Immunol. 160 1998 4719 4729
46. G.S. Prins Molecular biology of the androgen receptor Mayo Clin. Proc. 75 2000 S32 S35
47. S. Radoja, M. Saio, D. Schaer, M. Koneru, S. Vukmanovic, and A.B. Frey CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis J. Immunol. 167 2001 5042 5051
48. F. Ramsdell, and B.J. Fowlkes Maintenance of in vivo tolerance by persistence of antigen Science 257 1992 1130 1134
49. P.S. Rennie, N. Bruchovsky, K.J. Leco, P.C. Sheppard, S.A. McQueen, H. Cheng, R. Snoek, A. Hamel, M.E. Bock, and B.S. MacDonald Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene Mol. Endocrinol. 7 1993 23 36
50. A.C. Roden, M.T. Moser, S.D. Tri, M. Mercader, S.M. Kuntz, H. Dong, A.A. Hurwitz, D.J. McKean, E. Celis, and B.C. Leibovich Augmentation of T cell levels and responses induced by androgen deprivation J. Immunol. 173 2004 6098 6108
51. P. Shrikant, A. Khoruts, and M.F. Mescher CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism Immunity 11 1999 483 493
52. M.T. Spiotto, P. Yu, D.A. Rowley, M.I. Nishimura, S.C. Meredith, T.F. Gajewski, Y.X. Fu, and H. Schreiber Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells Immunity 17 2002 737 747
53. K. Staveley-O'Carroll, E. Sotomayor, J. Montgomery, I. Borrello, L. Hwang, S. Fein, D. Pardoll, and H. Levitsky Induction of antigen-specific T cell anergy: An early event in the course of tumor progression Proc. Natl. Acad. Sci. USA 95 1998 1178 1183
54. R.M. Steinman, S. Turley, I. Mellman, and K. Inaba The induction of tolerance by dendritic cells that have captured apoptotic cells J. Exp. Med. 191 2000 411 416
55. Y. Sugimura, G.R. Cunha, and A.A. Donjacour Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate Biol. Reprod. 34 1986 973 983
56. M.E. Taplin, and S.P. Balk Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence J. Cell. Biochem. 91 2004 483 490
57. A.R. Townsend, A.J. McMichael, N.P. Carter, J.A. Huddleston, and G.G. Brownlee Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells Cell 39 1984 13 25
58. S.M. Viselli, S. Stanziale, K. Shults, W.J. Kovacs, and N.J. Olsen Castration alters peripheral immune function in normal male mice Immunology 84 1995 337 342
59. W.F. Whitmore, and R.F. Gittes Studies on the prostate and testis as immunologically privileged sites Cancer Treat. Rep. 61 1977 217 222
60. C. Yee, S.R. Riddell, and P.D. Greenberg Prospects for adoptive T cell therapy Curr. Opin. Immunol. 9 1997 702 708
61. X.Y. Zhao, P.J. Malloy, A.V. Krishnan, S. Swami, N.M. Navone, D.M. Peehl, and D. Feldman Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor Nat. Med. 6 2000 703 706
62. X. Zheng, J.X. Gao, H. Zhang, T.L. Geiger, Y. Liu, and P. Zheng Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors J. Immunol. 169 2002 4761 4769